Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases.
Undas A, Ariëns RA.
Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e88-99. Epub 2011 Aug 11. Review.
Related citations
Joint effects of obesity and body height on the risk of venous thromboembolism: the Tromsø Study.
Borch KH, Nyegaard C, Hansen JB, Mathiesen EB, Njølstad I, Wilsgaard T, Brækkan SK.
Arterioscler Thromb Vasc Biol. 2011 Jun;31(6):1439-44. Epub 2011 Apr 28.
Update on venous thromboembolism: risk factors, mechanisms, and treatments.
Machlus KR, Aleman MM, Wolberg AS.
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):476-8. No abstract available.
Hypercoagulability and hypofibrinolysis and risk of deep vein thrombosis and splanchnic vein thrombosis: similarities and differences.
Smalberg JH, Kruip MJ, Janssen HL, Rijken DC, Leebeek FW, de Maat MP.
Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):485-93. Review.
C-reactive protein and risk of venous thromboembolism in the general population.
Zacho J, Tybjaerg-Hansen A, Nordestgaard BG.
Arterioscler Thromb Vasc Biol. 2010 Aug;30(8):1672-8. Epub 2010 May 13.
Current treatment of venous thromboembolism.
Key NS, Kasthuri RS.
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):372-5. Epub 2010 Feb 5. Review.
Periprocedural anticoagulation management of patients with venous thromboembolism.
McBane RD, Wysokinski WE, Daniels PR, Litin SC, Slusser J, Hodge DO, Dowling NF, Heit JA.
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):442-8. Epub 2010 Feb 5.
Coagulation factor IXa as a target for treatment and prophylaxis of venous thromboembolism.
Eikelboom JW, Zelenkofske SL, Rusconi CP.
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):382-7. Epub 2010 Feb 5. Review.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on